Guideline for Chronic Coronary Syndrome - 2025.

Arq Bras Cardiol · 2025 · PMC13400070 · PMID 41294178

Europe PMC DOI

hedged sentences

0.8240

closest p · 16.5× alpha

0.8240

boldest claim

The sentences

did not reach statistical significancep = 0.824not close (p > 0.1)

31.0%, p = 0.089), although this did not reach statistical significance; at 5 years, mortality was 12.8% vs. 16.2% (p = 0.824).

also in 111,027 other papers

nominally significantno p-value reported

CABG significantly reduced sudden deaths and deaths due to MI, with a nominally significant effect on fatal pump failure events.

also in 7,732 other papers

did not achieve significanceno p-value reported

The treatment did not achieve significance in the primary endpoint – a composite of all-cause mortality, nonfatal MI (including silent MI), stroke, ACS, endovascular or surgical intervention in coronary or lower limb arteries, or above-ankle amputation (HR 0.90, 95% CI 0.80-1.02, p = 0.095).

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.